Wilmer Eye Institute

Baltimore, Maryland 21287-9277

5 studies enrolling now · 47 studies all time

What they study most

AMD, Age Related Macular Degeneration, Age-related Macular Degeneration, Amblyopia, Anterior Uveitis, CNV, COVID-19, Choroidal Neovascularization, Combretastatin A4 Phosphate, Conjunctivitis, Diabetic Macular Edema, Diabetic Retinopathy

Studies at this site

• Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease — Recruiting now
• Neoadjuvant Darovasertib in Primary Uveal Melanoma — Recruiting now
• Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age — Recruiting now
• Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age — Recruiting now
• A Randomized Trial to Evaluate Sequential vs Simultaneous Patching — Recruiting now
• Full-Time Occlusion Therapy for Intermittent Exotropia in Children — Completed
• Binocular Dig Rush Game Treatment for Amblyopia — Completed
• Trial of Overminus Spectacle Therapy for Intermittent Exotropia — Completed
• A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease — Stopped early
• RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD) — Completed
• Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic — Completed
• Base-in Prism Spectacles for Intermittent Exotropia — Completed
• Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit — Completed
• Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy — Stopped early
• Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases — Stopped early
• Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE) — Stopped early
• A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema — Completed
• Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy — Completed
• A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device — Completed
• Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) — Stopped early
• The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism — Completed
• The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy — Completed
• Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO — Completed
• Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration — Completed
• Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1) — Completed
• Biomarkers In Retinitis Pigmentosa (BIRP) — Completed
• Diabetic Macular Edema Treated With Ozurdex (DMEO) — Completed
• Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia — Completed
• Levodopa for the Treatment of Residual Amblyopia — Completed
• Ozurdex for Retinal Vein Occlusion Study (ORVO Study) — Completed
• Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema — Stopped early
• Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia — Completed
• Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions — Completed
• Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis — Completed
• A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis — Completed
• Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora — Completed
• Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD — Completed
• A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis — Completed
• A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis — Completed
• Study of Surgical Procedures for Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 Years Old — Completed
• Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia — Completed
• Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia — Completed
• Trial Comparing Daily Atropine Versus Weekend Atropine — Completed
• An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old — Completed
• Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old — Completed
• Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) — Completed